Citations

Clear

5374 citation(s) found for "St Louis, E K".

O5‐03‐01: Apolipoprotein E Genotype Differentially Modulates Effects of ANTI‐AB Immunotherapy
Pankiewicz, Joanna, Baquero‐Buitrago, Jairo, Sanchez, Sandrine , Lopez-Contreras, Jennifer, Hoang, M.D. Le, Bard, Frédérique, Sullivan, Patrick M. , Wadghiri, Youssef Zaim , Kim, Jungsu , Holtzman, David M. , Sadowski, Martin

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2016.06.716 Get It

IC‐P‐142: A Longitudinal Morphometric Study of Familial Alzheimer’s Disease: Results from Dian
Kinnunen, Kirsi M. , Network, The Dominantly Inherited Alzheimer, Cash, David M. , Ridgway, Gerard R. , Benzinger, Tammie L.S. , Wallon, David , Jack, Clifford R. , Bateman, Randall J. , Morris, John C. , Rossor, Martin N. , Ourselin, Sébastien , Fox, Nick C. , Network, The Dominantly Inherited Alzheimer

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_2 | Pages: No page available

10.1016/j.jalz.2016.06.172 Get It

F5‐02‐03: BDNF VAL66MET Moderates Cognitive Impairment, Neuronal Dysfunction and TAU in Preclinical Autosomal Dominant Alzheimer's Disease
Fagan, Anne M. , Benzinger, Tammie Lee Smith, Ricardo, Allegri, Chhatwal, Jasmeer P. , Farlow, Martin R. , Graff‐Radford, Neill R. , Laske, Christoph , Ringman, John M. , Salloway, Stephen , Lim, Yen Ying , Hassenstab, Jason , Cruchaga, Carlos , Goate, Alison , Benzinger, Tammie L.S. , Maruff, Paul , Snyder, Peter J. , Masters, Colin L. , Allegri, Ricardo , Xiong, Chengjie , McDade, Eric , Rossor, Martin N. , Schofield, Peter William , Holtzman, David M. , Morris, John C. , Bateman, Randall J.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2016.06.689 Get It

O1‐07‐01: A Longitudinal Morphometric Study of Familial Alzheimer’s Disease: Results From DIAN
Kinnunen, Kirsi M. , Network, The Dominantly Inherited Alzheimer, Cash, David M. , Ridgway, Gerard R. , Benzinger, Tammie L.S. , Wallon, David , Jack, Clifford R. , Bateman, Randall J. , Morris, John Charles , Rossor, Martin N. , Ourselin, Sébastien , Fox, Nick C. , Network, The Dominantly Inherited Alzheimer

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_4 | Pages: No page available

10.1016/j.jalz.2016.06.329 Get It

O2‐03‐02: are White Matter Hyperintensities a Core Feature of Alzheimer’s Disease or Just a Reflection of Amyloid Angiopathy? Evidence From the Dominantly Inherited Alzheimer Network (DIAN)
Zimmerman, Molly E. , Viqar, Fawad, Narkhede, Atul, Benzinger, Tammie Lee Smith, Marcus, Daniel S., Cairns, Nigel J. , Buckles, Virginia, Saykin, Andy J., Ringman, John M. , Ryan, Natalie S. , Förster, Stefan , Laske, Christoph , Salloway, Stephen , Correia, Stephen , Weiner, Michael W. , Mayeux, Richard , Lee, Seonjoo , Tosto, Giuseppe , Goate, Alison , Fox, Nick C. , Holtzman, David M. , Ghetti, Bernardino , McDade, Eric , Martins, Ralph N. , Saykin, Andy J., Masters, Colin L. , Schofield, Peter R. , Sperling, Reisa Anne , Bateman, Randall J. , Morris, John C. , Jack, Clifford R. , Brickman, Adam M.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_4 | Pages: No page available

10.1016/j.jalz.2016.06.406 Get It

Benchmarks for the interpretation of esophageal high‐resolution manometry
Keswani, Rajesh N. , Dunbar, Kerry B., Gawron, Andrew J. , Gyawali, C. Prakash , Katz, Philip O. , Katzka, David A. , Tatum, Roger P. , Pandolfino, John E. , Yadlapati, Rena , Kahrilas, Peter J. , Spechler, Stuart Jon , Gyawali, C P

Mayo Clinic

Neurogastroenterology & Motility | October 14, 2016 | Volume: 29 | Issue: 4 | Pages: No page available

10.1111/nmo.12971 | PMID 27739183 Get It

AbstractBackgroundCompetent interpretation of esophageal high‐resolution manometry (HRM) is integral to a quality study. Currently, methods to assess physician competency for the interpretation of esophageal HRM do not exist. The aim of this study was to use formal techniques to (i) develop an HRM interpretation exam, and (ii) establish minimum competence benchmarks for HRM interpretation skills at the trainee, physician interpreter, and master level.MethodsA total of 29 physicians from 8 academic centers participated in the study: 9 content experts separated into 2 study groups—expert test‐takers (n=7) and judges (n=2), and 20 HRM inexperienced trainees (“trainee test‐taker”; n=20). We designed the HRM interpretation exam based on expert consensus. Expert and trainee test‐takers (n=27) completed the exam. According to the modified Angoff method, the judges reviewed the test‐taker performance and established minimum competency cut scores for HRM interpretation skills.Key ResultsThe HRM interpretation exam consists of 22 HRM cases with 8 HRM interpretation skills per case: identification of pressure inversion point, hiatal hernia >3 cm, integrated relaxation pressure, distal contractile integral, distal latency, peristaltic integrity, pressurization pattern, and diagnosis. Based on the modified Angoff method, minimum cut scores for HRM interpretation skills at the trainee, physician interpreter, and master level ranged from 65–80%, 85–90% (with the exception of peristaltic integrity), and 90–95%, respectively.Conclusions & InferencesUsing a formal standard setting technique, we established minimum cut scores for eight HRM interpretation skills across interpreter levels. This examination and associated cut scores can be applied in clinical practice to judge competency.
Hemifacial Spasm Secondary to Parotid Pleomorphic Adenoma With Stylomastoid Foramen Extension
Martin, Eliot J., Carlson, Matthew L. , Moore, Eric J. , Jackson, Ryan S.

Mayo Clinic

Otology & Neurotology | October 13, 2016 | Volume: 38 | Issue: 1 | Pages: 129-132

10.1097/mao.0000000000001256 | PMID 27755360 Get It

Objective: To report hemifacial spasm (HFS) as a rare presenting symptom of a benign parotid neoplasm involving the stylomastoid foramen. Methods: Case report with literature review. Results: An 18-year-old woman presented with a 1-year history of a progressively enlarging right infra-auricular mass with new onset ipsilateral severe HFS. Clinical vetting unveiled a palpable 2 cm, firm, minimally mobile mass medial to the angle of the mandible. Imaging revealed a heterogeneous intraparotid mass with tumor extension into the stylomastoid foramen. Diagnostic consideration was given to neurogenic tumors and neoplasms of parotid origin. The patient ultimately underwent superficial parotidectomy and the tumor was found superficial and extrinsic to the proximal facial nerve trunk but extended into the stylomastoid foramen. The tumor was removed after performing mastoidectomy with mastoid segment facial nerve decompression. Frozen section pathology was consistent with pleomorphic adenoma. Postoperatively the patient had normal facial nerve function with immediate and complete resolution of HFS. To date there are only three other published reports of benign parotid tumors presenting with HFS and this is the first illustrating intratemporal tumor extension. Conclusions: HFS is a rare presenting symptom associated with benign parotid neoplasms with scarce documentation in the literature. In this index case, tumor extirpation with mastoid segment facial nerve decompression provided immediate and durable resolution of symptoms.
Safety of Local Intracutaneous Lidocaine Anesthesia Used by Dermatologic Surgeons for Skin Cancer Excision and Postcancer Reconstruction: Quantification of Standard Injection Volumes and Adverse Event Rates
Alam, Murad , Schaeffer, Matthew, Geisler, Amelia, Poon, Emily , Fosko, Scott W. , Srivastava, Divya, Alam, Murad

Mayo Clinic

Dermatologic Surgery | October 12, 2016 | Volume: 42 | Issue: 12 | Pages: 1320-1324

10.1097/dss.0000000000000907 | PMID 27893492 Get It

BACKGROUND Intracutaneous lidocaine is used for anesthesia in dermatologic surgery for skin cancer excision and repair with exceedingly low incidence of reported adverse events. OBJECTIVE To measure (1) the quantity of lidocaine typically used for facial skin cancer excision and reconstruction; and (2) the frequency and character of associated adverse events. METHODS Survey study of dermatologic surgeons with longitudinal reporting. Reported practice during 10 business days: (1) mean volume of 1% lidocaine per skin cancer excision; (2) maximum per excision; (3) mean per reconstruction; and (4) maximum per reconstruction. RESULTS A total of 437 of 1,175 subjects contacted (37.2%) responded. Mean per excision was 3.44 mL (SD: 2.97), and reconstruction 11.70 mL (10.14). Maximum per excision was 6.54 mL (4.23), and reconstruction was 15.85 mL (10.39). No cases of lidocaine toxicity were reported, diagnosed, or treated. Incidence of adverse events possibly anesthesia related was >0.15%, with most (0.13%) being mild cases of dizziness, drowsiness, or lightheadedness from epinephrine tachycardia. CONCLUSION Toxicity associated with local anesthesia other than lidocaine was not studied. Volumes of lidocaine in skin cancer excision and repair are modest and within safe limits. Lidocaine toxicity is exceedingly rare to entirely absent. For comparable indications, lidocaine is safer than conscious sedation or general anesthesia.
Age at natural menopause genetic risk score in relation to age at natural menopause and primary open-angle glaucoma in a US-based sample
Pasquale, Louis R. , Bailey, Jessica N. Cooke , Lindström, Sara , Christen, William G. , Allingham, R. Rand, Ashley‐Koch, Allison E. , Lee, Richard K., Moroi, Sayoko E. , Brilliant, Murray H. , Wollstein, Gadi , Schuman, Joel S. , Fingert, John H. , Budenz, Donald L. , Realini, Tony , Gaasterland, Terry , Gaasterland, Douglas, Scott, William K. , Singh, Kuldev, Sit, Arthur J. , Igo, Robert P. , Song, Yeunjoo E. , Rhee, Douglas J. , Gulati, Vikas , Havens, Shane , Vollrath, Douglas, Medeiros, Felipe A. , Pericak‐Vance, Margaret A. , Kraft, Peter , Richards, Julia E. , Rosner, Bernard , Hauser, Michael A. , Haines, Jonathan L. , Wiggs, Janey L. , Aschard, Hugues , Kang, Jae Hee , Chasman, Daniel I. , Hark, Lisa A. , Ritch, Robert , Zack, Donald J. , Weinreb, Robert Neal , Liu, Yutao , Kraft, Peter , Moroi, Sayoko E , Schuman, Joel S , Sit, Arthur J

Mayo Clinic

Menopause | October 12, 2016 | Volume: 24 | Issue: 2 | Pages: 150-156

10.1097/gme.0000000000000741 | PMID 27760082 Get It

Abstract Objective: Several attributes of female reproductive history, including age at natural menopause (ANM), have been related to primary open-angle glaucoma (POAG). We assembled 18 previously reported common genetic variants that predict ANM to determine their association with ANM or POAG. Methods: Using data from the Nurses’ Health Study (7,143 women), we validated the ANM weighted genetic risk score in relation to self-reported ANM. Subsequently, to assess the relation with POAG, we used data from 2,160 female POAG cases and 29,110 controls in the National Eye Institute Glaucoma Human Genetics Collaboration Heritable Overall Operational Database (NEIGHBORHOOD), which consists of 8 datasets with imputed genotypes to 5.6+ million markers. Associations with POAG were assessed in each dataset, and site-specific results were meta-analyzed using the inverse weighted variance method. Results: The genetic risk score was associated with self-reported ANM (P = 2.2 × 10–77) and predicted 4.8% of the variance in ANM. The ANM genetic risk score was not associated with POAG (Odds Ratio (OR) = 1.002; 95% Confidence Interval (CI): 0.998, 1.007; P = 0.28). No single genetic variant in the panel achieved nominal association with POAG (P ≥0.20). Compared to the middle 80 percent, there was also no association with the lowest 10th percentile or highest 90th percentile of genetic risk score with POAG (OR = 0.75; 95% CI: 0.47, 1.21; P = 0.23 and OR = 1.10; 95% CI: 0.72, 1.69; P = 0.65, respectively). Conclusions: A genetic risk score predicting 4.8% of ANM variation was not related to POAG; thus, genetic determinants of ANM are unlikely to explain the previously reported association between the two phenotypes.
Comparing performance of 30‐day readmission risk classifiers among hospitalized primary care patients
Garrison, Gregory M. , Robelia, Paul M., Pecina, Jennifer L. , Dawson, Nancy L. , Pecina, Jennifer

Mayo Clinic

Journal of Evaluation in Clinical Practice | October 7, 2016 | Volume: 23 | Issue: 3 | Pages: 524-529

10.1111/jep.12656 | PMID 27696638 Get It

AbstractRationale, aims and objectivesHospital readmission within 30 days of discharge occurs in almost 20% of US Medicare patients and may be a marker of poor quality inpatient care, ineffective hospital to home transitions, or disease severity. Within a patient centered medical home, care transition interventions may only be practical from cost and staffing perspectives if targeted at patients with the greatest risk of readmission. Various scoring algorithms attempt to predict patients at risk for 30‐day readmission, but head‐to‐head comparison of performance is lacking. Compare published scoring algorithms which use generally available electronic medical record data on the same set of hospitalized primary care patients.MethodsThe LACE index, the LACE+ index, the HOSPITAL score, and the readmission risk score were computed on a consecutive cohort of 26,278 hospital admissions. Classifier performance was assessed by plotting receiver operating characteristic curves comparing the computed score with the actual outcome of death or readmission within 30 days. Statistical significance of differences in performance was assessed using bootstrapping techniques.ResultsCorrect readmission classification on this cohort was moderate with the following c‐statistics: Readmission risk score 0.666; LACE 0.680; LACE+ 0.662; and HOSPITAL 0.675. There was no statistically significant difference in performance between classifiers.ConclusionsLogistic regression based classifiers yield only moderate performance when utilized to predict 30‐day readmissions. The task is difficult due to the variety of underlying causes for readmission, nonlinearity, and the arbitrary time period of concern. More sophisticated classification techniques may be necessary to increase performance and allow patient centered medical homes to effectively focus efforts to reduce readmissions.